680199-06-8
Chemical Structure
PR-104A
Synonym(s): SN 27858
- CAS No.: 680199-06-8
- Formula:C14H19BrN4O9S
- Molecular Weight:499.29
IUPAC Name: 2-((2-bromoethyl)(2-((2-hydroxyethyl)carbamoyl)-4,6-dinitrophenyl)amino)ethyl methanesulfonate
InChIKey: AZICEEZSDKZDHX-UHFFFAOYSA-N
SMILES: BrCCN(CCOS(=O)(C)=O)C1=C(C(NCCO)=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O
Biological Activity: PR-104A (SN 27858) is the alcohol metabolite of phosphate proagent PR-104. PR-104A is a hypoxia-selective DNA cross-linking agent/DNA-damaging agent and cytotoxin. Antitumor Activity[1]. PR-104A is metabolized under hypoxia by the 1-electron NADPH:cytochrome P450 oxidoreductase. PR-104A can be used for the research of relapsed/refractory T-lineage acute lymphoblastic leukemia (T-ALL)[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PR-104A | 98.98% | PR-104A (SN 27858) is the alcohol metabolite of phosphate proagent PR-104. PR-104A is a hypoxia-selective DNA cross-linking agent/DNA-damaging agent and cytotoxin. Antitumor Activity. PR-104A is metabolized under hypoxia by the 1-electron NADPH:cytochrome P450 oxidoreductase. PR-104A can be used for the research of relapsed/refractory T-lineage acute lymphoblastic leukemia (T-ALL). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.86
HY-16405PR-104 -
Similarity Score 0.84
HY-16406PR-104 sodium -
Similarity Score 0.51
HY-149769CP-506 -
Similarity Score 0.50
HY-120313SN23862 -
Similarity Score 0.50
HY-W714201Nitralin -
Similarity Score 0.50
HY-147092Oryzalin -
Similarity Score 0.49
HY-149769ACP-506 mesylate -
Similarity Score 0.48
HY-130467DNP-NH-PEG2-C2-acid -
Similarity Score 0.48
HY-W280531S1DNSAH-15N2 -
Explore the MedChemAI to find more analogs
References
- [1]. Adam V Patterson, et al. Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104. Clin Cancer Res. 2007 Jul 1;13(13):3922-32. [Content Brief]
- [2]. Donya Moradi Manesh, et al. AKR1C3 is a biomarker of sensitivity to PR-104 in preclinical models of T-cell acute lymphoblastic leukemia. Blood. 2015 Sep 3;126(10):1193-202. [Content Brief]
